Tandem Diabetes Care Inc

TNDM: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
ph$LOCK|s%LOCK|<Qfmzk

Tandem Earnings: Few Surprises as the Firm Makes Progress With Mobi Pump

Tandem Diabetes posted second-quarter revenue growth of 6% and approximately halved its negative earnings year over year. Management maintained its outlook, and shares barely bobbled.

Sponsor Center